Clinical trial
Using Drug Levels in the Blood to Guide Therapy in HIV Infected Patients Taking…
NCT00041769 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00041769 |
|---|---|
| Title | Using Drug Levels in the Blood to Guide Therapy in HIV Infected Patients Taking a Protease Inhibitor |
| Official title | A Phase II Randomized Controlled Trial Evaluating the Impact of Therapeutic Drug Monitoring (TDM) on Virologic Response to a Salvage Regimen in Subjects With a Normalized Inhibitory Quotient (NIQ) Less Than or Equal to 1 to One or More Protease Inhibitors |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Procedure |
| Interventions | Therapeutic Drug Monitoring (TDM) |
| Enrollment | 360 |
| Start date | Jun 1, 2002 |
| Primary completion | Apr 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Jul 17, 2002 |
| Last update posted | Jul 13, 2010 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: